Atlas Trials

Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza

Clinical trial NCT03901001 · UNKNOWN

Trial details

NCT number
NCT03901001
Sponsor
Chinese University of Hong Kong
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2023-05-08
Primary completion
2025-10-31
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.